Amesite Reports 63% Revenue Growth from NurseMagic™ Enterprise; Announces Launch of AI-Powered Government Form-Fill Automation to Reduce Reporting Burden
Amesite (NASDAQ: AMST), an AI-powered enterprise solutions developer, reported 63% revenue growth for its NurseMagic™ platform following the July 14, 2025 launch of its census-based Enterprise subscription model. The company announced that Enterprise sales have surpassed B2C sales, driven by post-acute care providers seeking scalable compliance solutions.
Amesite also launched an AI-powered automated form fill solution for government forms, specifically targeting the upcoming Centers for Medicare & Medicaid Services (CMS) mandate for Hospice Outcomes and Patient Evaluation (HOPE) assessment. The solution aims to help healthcare organizations auto-populate complex forms, reduce administrative time, and ensure full reimbursements in a market growing at a CAGR of 8%.
Amesite (NASDAQ: AMST), sviluppatore di soluzioni aziendali basate sull'IA, ha registrato una crescita dei ricavi del 63% per la sua piattaforma NurseMagic™ dopo il lancio, avvenuto il 14 luglio 2025, del modello di abbonamento Enterprise basato sulla censitura. L'azienda ha comunicato che le vendite Enterprise hanno superato quelle B2C, spinte da fornitori di assistenza post-acuta alla ricerca di soluzioni di conformità scalabili.
Amesite ha inoltre introdotto una soluzione automatizzata di compilazione moduli potenziata dall'IA per i moduli governativi, con focus sul prossimo mandato dei Centers for Medicare & Medicaid Services (CMS) relativo alla valutazione Hospice Outcomes and Patient Evaluation (HOPE). La soluzione è pensata per aiutare le organizzazioni sanitarie a precompilare moduli complessi, ridurre i tempi amministrativi e garantire rimborsi completi in un mercato che cresce a un CAGR dell'8%.
Amesite (NASDAQ: AMST), desarrollador de soluciones empresariales impulsadas por IA, informó un crecimiento de ingresos del 63% en su plataforma NurseMagic™ tras el lanzamiento, el 14 de julio de 2025, de su modelo de suscripción Enterprise basado en el censo. La compañía anunció que las ventas Enterprise han superado a las B2C, impulsadas por proveedores de atención post-aguda que buscan soluciones de cumplimiento escalables.
Amesite también lanzó una solución de llenado automático de formularios impulsada por IA para formularios gubernamentales, dirigida específicamente al próximo mandato de los Centers for Medicare & Medicaid Services (CMS) sobre la evaluación Hospice Outcomes and Patient Evaluation (HOPE). La solución pretende ayudar a las organizaciones sanitarias a autocompletar formularios complejos, reducir el tiempo administrativo y asegurar reembolsos completos en un mercado que crece a un CAGR del 8%.
Amesite (NASDAQ: AMST)는 AI 기반 엔터프라이즈 솔루션 개발업체로, 2025년 7월 14일 인구 기준(센서스) Enterprise 구독 모델 출시 이후 자사 NurseMagic™ 플랫폼의 매출이 63% 증가
Amesite는 또한 정부 양식용으로 설계된 AI 기반 자동 양식 작성 솔루션을 출시했으며, 특히 CMS(Centers for Medicare & Medicaid Services)의 새로운 Hospice Outcomes and Patient Evaluation(HOPE) 평가 의무화에 대응하는 것을 목표로 합니다. 이 솔루션은 의료 기관이 복잡한 양식을 자동으로 채우고 행정 시간을 줄이며 완전한 환급을 보장하도록 돕도록 설계되었으며, 관련 시장은 연평균 성장률(CAGR) 8%로 성장하고 있습니다.
Amesite (NASDAQ: AMST), développeur de solutions d'entreprise alimentées par l'IA, a annoncé une croissance des revenus de 63% pour sa plateforme NurseMagic™ suite au lancement, le 14 juillet 2025, de son modèle d'abonnement Enterprise basé sur le recensement. L'entreprise a indiqué que les ventes Enterprise ont dépassé les ventes B2C, tirées par des prestataires de soins post-aigus recherchant des solutions de conformité évolutives.
Amesite a également lancé une solution automatisée de remplissage de formulaires alimentée par l'IA pour les formulaires gouvernementaux, ciblant spécifiquement le prochain mandat des Centers for Medicare & Medicaid Services (CMS) concernant l'évaluation Hospice Outcomes and Patient Evaluation (HOPE). La solution vise à aider les organisations de santé à préremplir automatiquement des formulaires complexes, à réduire le temps administratif et à garantir des remboursements complets sur un marché en croissance à un Taux de croissance annuel composé (CAGR) de 8%.
Amesite (NASDAQ: AMST), ein Entwickler KI-gestützter Unternehmenslösungen, meldete nach dem Start seines census-basierten Enterprise-Abonnementmodells am 14. Juli 2025 ein Umsatzwachstum von 63% für die Plattform NurseMagic™. Das Unternehmen gab bekannt, dass Enterprise-Verkäufe die B2C-Verkäufe übertroffen haben, getrieben von post-akuten Pflegeanbietern, die skalierbare Compliance-Lösungen suchen.
Amesite hat außerdem eine KI-gestützte automatisierte Formularausfülllösung für Regierungsformulare eingeführt, die speziell auf das bevorstehende Mandat der Centers for Medicare & Medicaid Services (CMS) zur Hospice Outcomes and Patient Evaluation (HOPE) abzielt. Die Lösung soll Gesundheitsorganisationen helfen, komplexe Formulare automatisch vorzubefüllen, Verwaltungszeiten zu reduzieren und vollständige Erstattungen sicherzustellen — in einem Markt mit einem CAGR von 8%.
- Revenue growth of 63% for NurseMagic platform
- Enterprise sales surpassing B2C sales, indicating successful business model transition
- Launch of AI-powered HOPE automation solution addressing upcoming regulatory requirements
- Operating in post-acute care market with 8% CAGR growth rate
- None.
Insights
Amesite's 63% revenue growth from NurseMagic Enterprise and new AI form automation position it well in expanding post-acute care market.
Amesite's 63% revenue growth for its NurseMagic platform signals strong market validation for its AI-powered enterprise approach in the post-acute care sector. The shift from B2C to Enterprise sales represents a strategic pivot with significantly higher revenue potential per customer. Rather than selling to individual healthcare workers, Amesite now targets entire organizations with census-based pricing that scales with patient populations.
The timing of their new AI-powered government form automation is particularly strategic ahead of CMS's mandatory HOPE assessment implementation in October. This regulatory change will substantially increase documentation requirements for hospice providers already facing staffing shortages. By automating these complex documentation processes, Amesite addresses a critical pain point that directly impacts reimbursement rates for providers.
What's most significant is Amesite's differentiated approach from traditional EMR vendors. While legacy systems often add documentation burden, Amesite's AI automation promises to reduce administrative time while maintaining compliance - essentially allowing providers to handle more patients without proportionally increasing staff. This positions them advantageously in the post-acute care market, which is growing at an 8% CAGR, outpacing acute care.
The company's focus on ensuring full reimbursement rates through compliant documentation directly addresses a top financial concern for healthcare providers. With increasing regulatory scrutiny, solutions that can simultaneously reduce administrative burden while improving compliance represent substantial value in this specialized market segment.
DETROIT, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today announced
"We’re no longer just selling to employees – we’re selling to serve every patient in the system and help organizations leverage AI technology as a true competitive advantage," said Brandon Owens, VP of Sales at Amesite. "That changes the game. The total addressable market is exponentially larger, and our pricing reflects the performance of our solution. Customers are choosing NurseMagic™ Enterprise to scale operations without adding staff, addressing one of the greatest costs in healthcare."
The announcement comes as the Centers for Medicare & Medicaid Services (CMS) prepares to mandate the Hospice Outcomes and Patient Evaluation (HOPE) assessment this October – a regulatory overhaul expected to significantly increase documentation burden per patient and strain already thin hospice staffing cohort. Amesite’s AI-powered HOPE automation solution, within NurseMagic™ Enterprise, is designed to enable organizations to auto-populate complex forms, cut administrative time, and assure full reimbursements.
"The government’s scrutiny of documentation is intensifying, and many organizations are unprepared," said Kalie Wortinger, Senior Engineering Manager at Amesite. "With the HOPE requirement looming, providers are seeking a solution that enables compliant, reimbursable submission of documentation. NurseMagic™ Enterprise has modular intelligence that enables our customers to document compliantly, and to be fully reimbursed for the crucial work they do."
"We’ve taken an entirely different approach from traditional EMR vendors," said Dr. Ann Marie Sastry, CEO of Amesite. "Our platform reimagines how post-acute care organizations handle regulatory requirements, enabling them to leverage our AI-powered tools to scale operations without adding staff. We specifically designed our solution to be an essential edge for customers, in a highly competitive, and demographically inevitable, market."
The post-acute care market is growing faster than the acute care market at a CAGR of
Post-acute care owners can book a demo to learn more about NurseMagic™’s HOPE solution here.
About Amesite Inc.
Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the
Forward-Looking Statements
This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations
FAQ
What was Amesite's (NASDAQ: AMST) revenue growth for NurseMagic in 2025?
What is Amesite's new AI-powered solution for healthcare providers?
How is Amesite addressing the upcoming CMS HOPE mandate?
What is the growth rate of the post-acute care market where Amesite operates?
How has Amesite's business model evolved with NurseMagic?
